Price $192.31 |
Market Cap
9.28B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
35.9
|
P/B
9.05
|
P/S
11.38
|
Dividend %
-
|
|
P/CF
233.1
|
P/FCF
40.4
|
Op. Cash Flow
270.2K
|
FCF
4.9
|
|
Op. Margin
30.00%
|
Net Margin
32.40%
|
ROE
28.80%
|
ROI
23.50%
|
|
ROA
25.60%
|
EPS Growth
54.00%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $38.97 | - | - | 1.04B | Strong Buy |
| TearLab Corp (TEAR) | $0.06 | - | - | 900K | Strong Buy |
| CVS Health Corp (CVS) | $61.39 | - | 3.60% | 71.93B | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.52 | - | - | 28.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.96 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
